6,7-Dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxylic acid

Catalog No.: 
ACAFPG591
CAS No.: 
718621-99-9
Molecular Formula: 
C7H8N2O3
Molecular Weight: 
168.15
6,7-Dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$155.00In stockInquiry
250mg95%$240.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6,7-Dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxylic acid
IUPAC Name6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxylic acid
MDL No.MFCD16171771
Molecular FormulaC7H8N2O3
Molecular Weight168.15
SMILESO=C(C1=NN2C(OCCC2)=C1)O
InChI KeyYFZDKAJETNSREY-UHFFFAOYSA-N
Synonym5H-Pyrazolo[5,1-b][1,3]oxazine-2-carboxylicacid,6,7-dihydro-(9CI);6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxylic acid;5H,6H,7H-pyrazolo[3,2-b][1,3]oxazine-2-carboxylic acid;5H-Pyrazolo[5,1-b][1,3]oxazine-2-carboxylic acid, 6,7-dihydro-
CAS No.718621-99-9
PubChem CID21941386

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P264-P270-P301+P312+P330-P501

Synthetic Route by SureRoute

1. ACAFPG591 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTGUW689 route compound structure diagram
    ACTGUW689153597-59-2In Stock
  2. Then
  3. ACAFPG591 route product structure diagram
    ACAFPG591718621-99-9In Stock
Inquiry

2. ACAFPG591 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACAFPG591 route product structure diagram
    ACAFPG591718621-99-9In Stock
Inquiry

3. ACAFPG591 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACAFPG591 route product structure diagram
    ACAFPG591718621-99-9In Stock
Inquiry

Comments (0)